ImmuCell Corp Files Q1 2025 10-Q
Ticker: ICCC · Form: 10-Q · Filed: May 14, 2025 · CIK: 811641
| Field | Detail |
|---|---|
| Company | Immucell Corp /De/ (ICCC) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, healthcare
Related Tickers: ICCC
TL;DR
ImmuCell (ICCC) filed its Q1 2025 10-Q. Check financials.
AI Summary
ImmuCell Corporation filed its 10-Q for the quarterly period ended March 31, 2025. The company, incorporated in Delaware and headquartered in Portland, Maine, reported on its financial performance. ImmuCell Corporation's common stock is traded on The Nasdaq Capital Market under the symbol ICCC.
Why It Matters
This filing provides investors with an update on ImmuCell Corporation's financial health and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.
Key Players & Entities
- ImmuCell Corporation (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- Delaware (jurisdiction) — State of Incorporation
- Portland, ME (location) — Principal executive office location
- ICCC (ticker) — Trading symbol for Common Stock
- The Nasdaq Capital Market (exchange) — Exchange where Common Stock is registered
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is ImmuCell Corporation.
In which state was ImmuCell Corporation incorporated?
ImmuCell Corporation was incorporated in Delaware.
What is the trading symbol for ImmuCell Corporation's common stock?
The trading symbol for ImmuCell Corporation's common stock is ICCC.
On which exchange is ImmuCell Corporation's common stock registered?
ImmuCell Corporation's common stock is registered on The Nasdaq Capital Market.
For what quarterly period is this 10-Q report filed?
This 10-Q report is filed for the quarterly period ended March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding IMMUCELL CORP /DE/ (ICCC).